Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Moderna Q2: Focus On The Light At The End Of The Tunnel
08:30am, Friday, 02'nd Aug 2024
Moderna investors suffered a 20% hammering yesterday as the market reacted to a downward guidance revision. However, Covid isn't expected to disappear. The market reset should help prime MRNA for a se
Cathie Wood's Ark ETFs buy a bunch of Moderna stock after record selloff
08:20am, Friday, 02'nd Aug 2024
High-profile investor Cathie Wood saw the record selloff in Moderna Inc.'s stock as an opportunity to bulk up her bets on the biotechnology company.
7 Stocks' Revenue Totally Smashes All Expectations
07:00am, Friday, 02'nd Aug 2024
It may be earnings season for the S&P 500 — but revenue is on top of many investors' minds.
3 AI-Powered Healthcare Stocks Transforming Medicine
06:43am, Friday, 02'nd Aug 2024
AI healthcare stocks can potentially revolutionize patient care as we know it. The groundbreaking technology is expected to have a pervasive impact on the investment world, with its most profound anti
MRNA Investors Have Opportunity to Join Moderna, Inc. Fraud Investigation with the Schall Law Firm
07:33pm, Thursday, 01'st Aug 2024
LOS ANGELES--(BUSINESS WIRE)--MRNA Investors Have Opportunity to Join Moderna, Inc. Fraud Investigation with the Schall Law Firm.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
06:55pm, Thursday, 01'st Aug 2024
NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to conta
S&P 500 Gains and Losses Today: Moderna Drops as Soft Vaccine Demand Prompts Guidance Cut
06:01pm, Thursday, 01'st Aug 2024
Major U.S. equities indexes moved lower on the first day of August as a pair of reports elevated concerns about the trajectory of the U.S. economy.
Crude Oil Moves Lower; Moderna Shares Plunge
02:34pm, Thursday, 01'st Aug 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index dipping more than 650 points on Thursday.
Stock Of The Day: Moderna Stock Plunges, Breaking Key Support Levels Following Earnings Report
02:32pm, Thursday, 01'st Aug 2024
Moderna, Inc. MRNA shares are getting hit because of a bad earnings report. The Street didn't like the numbers.
Moderna (MRNA) Q2 2024 Earnings Call Transcript
12:58pm, Thursday, 01'st Aug 2024
Moderna Inc. (NASDAQ:MRNA ) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Stéphane Bancel - Chief Executive Officer Stephen Hoge - President Jamey Mock - Chief Finan
Moderna (MRNA) Q2 Earnings Beat, Stock Down on Guidance Slash
12:55pm, Thursday, 01'st Aug 2024
Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for its marketed products and low sales in the EU.
Moderna shares dive on slashed 2024 sales forecast
12:16pm, Thursday, 01'st Aug 2024
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plummeted almost 20% after the vaccine maker slashed its full-year sales forecast for respiratory vaccines by up to $1 billion. It now expects product sales f
Moderna's Revenue Warning Sends the Stock Into the Red for 2024
11:31am, Thursday, 01'st Aug 2024
Moderna (MRNA) shares plunged after the COVID-19 vaccine maker slashed its outlook on lower demand in Europe and a tough market in the U.S.
Moderna Stock Gaps Lower After Earnings
10:37am, Thursday, 01'st Aug 2024
Moderna Inc (NASDAQ:MRNA) stock is freefalling this morning, last seen down 15.2% to trade at $95.48 and pacing for its worst day since November 2021 after the company's second-quarter financial res
Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates
08:41am, Thursday, 01'st Aug 2024
Moderna (MRNA) came out with a quarterly loss of $3.33 per share versus the Zacks Consensus Estimate of a loss of $3.47. This compares to loss of $3.62 per share a year ago.
